71(top 1%)
papers
4.9K(top 1%)
citations
28(top 1%)
h-index
65(top 1%)
g-index
75
all documents
5.2K
doc citations
1.2K
citing journals

Top Articles

#TitleJournalYearCitations
1Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinomaNature Genetics20121,229
2Liver Transplantation for Hepatocellular Carcinoma: A Model Including α-Fetoprotein Improves the Performance of Milan CriteriaGastroenterology2012736
3Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosisJournal of Hepatology2017734
4Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort studyLancet, The2019449
5Effectiveness of Telaprevir or Boceprevir in Treatment-Experienced Patients With HCV Genotype 1 Infection and CirrhosisGastroenterology2014232
6Sofosbuvir plus ribavirin for hepatitis C virus-associated cryoglobulinaemia vasculitis: VASCUVALDIC studyAnnals of the Rheumatic Diseases2016136
7PET/CT in patients with hepatocellular carcinoma using [18F]fluorocholine: preliminary comparison with [18F]FDG PET/CTEuropean Journal of Nuclear Medicine and Molecular Imaging2006128
8Effect of viral suppression on hepatic venous pressure gradient in hepatitis C with cirrhosis and portal hypertensionJournal of Viral Hepatitis2017107
9Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patientsJournal of Hepatology2017100
10Paroxysmal nocturnal hemoglobinuria in Budd-Chiari Syndrome: Findings from a cohort studyJournal of Hepatology200998
11Early detection and curative treatment of hepatocellular carcinoma: A cost‐effectiveness analysis in France and in the United StatesHepatology201793
12Does regular blood transfusion prevent progression of cerebrovascular lesions in children with sickle cell disease?Annals of Hematology200965
13Long-term Efficacy of Interferon-Free Antiviral Treatment Regimens in Patients With Hepatitis C Virus–Associated Cryoglobulinemia VasculitisClinical Gastroenterology and Hepatology201963
14Boceprevir With Peginterferon Alfa-2a–Ribavirin Is Effective for Previously Treated Chronic Hepatitis C Genotype 1 InfectionClinical Gastroenterology and Hepatology201361
15Phase II study of sirolimus in treatment-naive patients with advanced hepatocellular carcinomaDigestive and Liver Disease201257
16Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence areaJHEP Reports202155
17Salvage liver transplantation or repeat hepatectomy for recurrent hepatocellular carcinoma: An intent‐to‐treat analysisLiver Transplantation201754
18Comparison of transient elastography (FibroScan), FibroTest, APRI and two algorithms combining these non‐invasive tests for liver fibrosis staging in HIV/HCV coinfected patients: ANRS CO13 HEPAVIH and FIBROSTIC collaborationHIV Medicine201450
19Transarterial chemoembolisation: effect of selectivity on tolerance, tumour response and survivalEuropean Radiology201149
20Pregnancy in women with portal vein thrombosis: Results of a multicentric European study on maternal and fetal management and outcomeJournal of Hepatology201246
21Evaluation of the Architect® tacrolimus assay in kidney, liver, and heart transplant recipientsJournal of Pharmaceutical and Biomedical Analysis201042
22Impact of tumour differentiation to select patients before liver transplantation for hepatocellular carcinomaLiver International201142
23Sofosbuvir/velpatasvir in patients with hepatitis C virus genotypes 1‐6 and compensated cirrhosis or advanced fibrosisLiver International201840
24Somatic calreticulin mutations in patients with Budd-Chiari syndrome and portal vein thrombosisHaematologica201539
25Budd-Chiari syndrome due to prothrombotic disorder: mid-term patency and efficacy of endovascular stentsEuropean Radiology200334
26Liver tumours in patients with Fanconi anaemia: a report of three casesEuropean Journal of Gastroenterology and Hepatology200832
27Combining imaging and tumour biopsy improves the diagnosis of combined hepatocellular‐cholangiocarcinomaLiver International201932
28Ultra‐short bowel is an independent risk factor for liver fibrosis in adults with home parenteral nutritionLiver International201830
29Oral Antibiotics Reduce Intestinal Necrosis in Acute Mesenteric Ischemia: A Prospective Cohort StudyAmerican Journal of Gastroenterology201928
30Complications after Hepatectomy for Hepatocellular Carcinoma Independently Shorten Survival: A Western, Single-Center AuditAnnals of Surgical Oncology201726
31Technical feasibility and safety of laparoscopic right hepatectomy for hepatocellular carcinoma following sequential TACE–PVE: a comparative studySurgical Endoscopy and Other Interventional Techniques201726
32Endpoints and New Options for Treatment of Chronic Hepatitis DHepatology202126
33Prospective evaluation of the management of hepatocellular carcinoma in the elderlyDigestive and Liver Disease201122
34STARTVerso1: A randomized trial of faldaprevir plus pegylated interferon/ribavirin for chronic HCV genotype-1 infectionJournal of Hepatology201519
35Diagnostic performance of controlled attenuation parameter for predicting steatosis grade in chronic hepatitis BAnnals of Hepatology201518
36LP28 : Efficacy of the oral sofosbuvir-based combinations in HCV genotype 4-mono-infected patients from the french observational cohort anrs CO22 hepatherJournal of Hepatology201518
37Diagnostic accuracy of the gamma-glutamyl transpeptidase to platelet ratio (GPR) using transient elastography as a referenceGut201716
38Proteomic analysis reveals that apolipoprotein A1 levels are decreased in patients with Budd–Chiari syndromeJournal of Hepatology201112
39Factors and Mechanisms Involved in Acquired Developmental Defects of Enamel: A Scoping ReviewFrontiers in Pediatrics202212
40Hepatobiliary MR contrast agents are useful to diagnose hepatocellular carcinoma in patients with Budd-Chiari syndromeJHEP Reports202011
41Efficacy and safety of elbasvir/grazoprevir for 8 or 12 weeks for hepatitis C virus genotype 4 infection: A randomized studyLiver International202010
42Predictive factors for hepatocellular carcinoma in chronic hepatitis B using structural equation modeling: a prospective cohort studyClinics and Research in Hepatology and Gastroenterology202110
43Nuclear magnetic resonance metabolomics and human liver diseases: The principles and evidence associated with protein and carbohydrate metabolismBiomedical Reports20179
44VKORC1 and CYP2C9 genetic polymorphisms in hepatic or portal vein thrombosisThrombosis Research20108
45P0795 : Safety and efficacy of sofosbuvir-containing regimens in the French observational cohort ANRS CO22 HEPATHERJournal of Hepatology20158
46Hepatopulmonary syndrome-attributed extreme hypoxemia and polycythemia revealing liver cirrhosisAmerican Journal of Emergency Medicine20198
47Hepatic sinusoidal obstruction syndrome induced by nivolumab in advanced melanoma: a case reportAnnals of Oncology20208
48Performance of non-invasive biomarkers compared with invasive methods for risk prediction of posthepatectomy liver failure in hepatocellular carcinomaBritish Journal of Surgery20227
49Liver transplantation for hepatocellular carcinoma: Time for an international consensusClinics and Research in Hepatology and Gastroenterology20126
50Efficacy and safety of the Met inhibitor tepotinib in patients (pts) with advanced Met+ hepatocellular carcinoma (HCC) previously treated with sorafenibAnnals of Oncology20186